Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2491
    -0.0020 (-0.16%)
     
  • Bitcoin GBP

    51,093.60
    -725.48 (-1.40%)
     
  • CMC Crypto 200

    1,332.23
    -64.31 (-4.60%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Company News For May 31, 2018

Texas Capital (TCBI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
  • salesforce.com inc.’s CRM shares rose 1.9% after posting fiscal first-quarter 2019 earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.18

  • HP Inc. HPQ increased 4% after reporting fiscal second-quarter 2018 revenues of $14,003 million, surpassing the Zacks Consensus Estimate of $13,585 million

  • Dick’s Sporting Goods Inc.’s DKS shares surged 25.8% after posting fiscal first quarter 2018 earnings of $0.59 per share, outpacing the Zacks Consensus Estimate of $0.42

  • Shares of Michael Kors Holdings Ltd. KORS plunged 11.5% after projecting fiscal 2019 earnings per share in the range of $4.65--$4.75, below the Zacks Consensus Estimate of $4.78


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
HP Inc. (HPQ) : Free Stock Analysis Report
 
Salesforce.com Inc (CRM) : Free Stock Analysis Report
 
DICK'S Sporting Goods, Inc. (DKS) : Free Stock Analysis Report
 
Michael Kors Holdings Limited (KORS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research